Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Gynecologic Oncology|February 16, 2019
Final report on serial phase II trials of all-intraperitoneal chemotherapy with or without bevacizumab for women with newly diagnosed, optimally cytoreduced carcinoma of Müllerian originC N Krasner, C Castro, R T Penson, et al.
Gynecologic Oncology|March 27, 2016
A SNaPshot of potentially personalized care: Molecular diagnostics in gynecologic cancerR T Penson, E Sales, L Sullivan, et al.
Oncogene|October 1, 2013
FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesisK Levanon, S Sapoznik, K Bahar-Shany, et al.
Gynecologic Oncology|December 3, 2017
Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data studyC A Hamilton, A Miller, Y Casablanca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2021
Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD IK N Moore, A M Oza, N Colombo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2018
Anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II studyS Banerjee, A M Oza, M J Birrer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2016
Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody-drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancerJ F Liu, K N Moore, M J Birrer, et al.
Oncogene|October 18, 2006
Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profilingY F Wong, T H Cheung, K W K Lo, et al.
Pageof 9